Creatine and Cancer Immunity: New Findings

A study published in the journal iScience has found that creatine, a compound best known for its role in muscle performance, may also play a role in supporting the immune system's ability to fight cancer, according to a news release from the University of California, Los Angeles (UCLA) [1]. The research, led by Lili Yang, a professor of microbiology, immunology and molecular genetics at UCLA and a member of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, examined the effect of creatine on dendritic cells, which are immune cells that coordinate the body's response against threats including tumors [2].

Dendritic cells act as scouts, capturing fragments of tumor cells and presenting them to T cells, which then launch a targeted attack [2]. The researchers discovered that dendritic cells unable to take up creatine had lower survival rates, weaker activation, and a reduced ability to prime cancer-fighting T cells, according to the study findings [1]. When creatine was added to normal dendritic cells, the cells showed increased energy, stronger activation, and greater production of signaling molecules that help coordinate an immune response, the report stated [1].

Study Design and Key Results

The study involved experiments using mouse immune cells, a mouse melanoma model, and human immune cells obtained from healthy donors, according to the UCLA researchers [2]. In mice with melanoma, creatine supplementation slowed tumor growth, and analysis of the tumors revealed higher numbers of activated dendritic cells and stronger T cell responses compared to untreated mice, the report stated [1]. Human dendritic cells treated with creatine showed enhanced activation and an improved ability to stimulate tumor-specific T cells, consistent with the mouse results, according to the study [2].

The researchers also noted that lower creatine levels have been observed in cancer patients, particularly those with advanced disease, often in connection with cachexia -- a severe form of muscle and weight loss that can accompany late-stage cancer [1]. A separate analysis of approximately 10 years of U.S. dietary data found an association between higher dietary creatine intake and a lower incidence of cancer, though the report stated that this observational finding does not prove cause and effect [1]. The condition of cachexia has been described as a physiological state where the body is in a catabolic cycle, and optimizing a patient's physiology can improve outcomes, according to experts quoted in discussions on cancer treatment [3].

Mechanism: How Creatine Supports Immune Cells

Dendritic cells require a steady supply of energy to function, particularly when detecting threats and communicating with other immune cells, the researchers explained [2]. Creatine helps cells maintain stable energy levels even under high demand, which is essential for dendritic cell activation and signaling [1]. The study found that creatine’s effect on energy levels directly influenced a key immune pathway that regulates inflammation and activation [1]. In cells with normal creatine uptake, supplementation enhanced this pathway; in cells that could not take up creatine, the pathway was suppressed, according to the report [1].

The compound creatine is converted into phosphocreatine, which helps regenerate adenosine triphosphate (ATP), the primary energy currency of cells [4]. Creatine kinase, an enzyme involved in this process, has been measured in various tissues including immune cells [4]. The UCLA study builds on earlier work from the same laboratory demonstrating that creatine also powers killer T cells, which directly attack tumor cells [2].

Implications and Next Steps

The findings are considered preclinical, and the report emphasizes that human trials are needed to confirm whether creatine supplementation improves cancer outcomes in people [1]. Creatine is described as a well-tolerated supplement with a well-documented safety profile and a growing body of research on its benefits beyond muscle, according to the researchers [1]. Standard dosing of 3 to 5 grams of creatine monohydrate per day is considered effective for supporting creatine levels [1].

Dendritic cell therapy is already used in some cancer treatment settings as an immune therapy, where dendritic cells are harvested from a patient’s blood, multiplied, and reintroduced to stimulate an immune response [5]. The new findings suggest that creatine could potentially serve as an adjunct to support such immunotherapies, though no definitive recommendations for cancer are made at this time [2]. The study adds to a growing body of research on creatine’s potential immune benefits, but investigators stated that additional research is necessary before any clinical applications can be recommended [2].

References

1. NaturalNews.com. "Creatine Supplement May Strengthen Immune System Against Cancer, UCLA Study Finds". July 10, 2026.
2. NaturalNews.com. "Study: Creatine Boosts Dendritic Cells, May Enhance Cancer Immunotherapy". June 18, 2026.
3. TheTruthAboutCancer.com. "A Global Quest 9 Episodes".
4. Parker, James N.; Parker, Philip M. "The Official Patient's Sourcebook On Trichinosis".
5. TheTruthAboutCancer.com. "QFTC Expert Interview Transcripts Final".

Explainer Infographic